In adherence to strict Non-Disclosure Agreements, Sedulo is unable to disclose identifiable information regarding our clients.
In the highly dynamic pet food market, Sedulo equipped a leading brand with deep CI throughout its brand planning cycle. Leveraging competitive benchmarking and primary market insights, the brand secured a sharper strategy and positioned itself decisively ahead of rival offerings.
In this early‑Alzheimer’s therapeutic space, Sedulo deployed a targeted intelligence initiative combining secondary research and trial data with primary interviews. The result was proactive flagging of competitor R&D moves and potential partnerships, informing strategic planning in a rapidly evolving market.
The Situation A global medical device manufacturer sought to deepen its competitive intelligence in the gastrointestinal (GI) space. As market dynamics evolved rapidly, driven by innovation in imaging systems, increased digitization, and shifting regulatory environments, the client aimed to benchmark its own R&D and sales strategies against key competitors in the GI medical device category. They needed to understand: How
The Situation A major national telecommunications company sought to gain validated and detailed insight into how its competitors were offering financing on mobile devices across the U.S. market. In an increasingly price-sensitive and digitally driven retail landscape, it was critical for the company to understand the nuances of competitor offers across: Multiple credit tiers Retail channels (in-store and online) Geographic
By developing detailed battlecards for three key competitors, Sedulo equipped an information security firm’s sales team with insights into pricing, packaging, roadmaps, messaging, and feature comparisons, enabling more confident rebuttals and a sharper competitive edge.
Leveraging a dual approach of secondary research and Primary Research using Sedulo’s Persistent Source Network™, this project delivered a comprehensive landscape intelligence program for PAH. It mapped evolving competitive pipelines, differentiators, and trial activity to support strategic decision-making in a complex therapeutic area.
